Drug intelligence / Profile preview

pyrogallol-o-sulfate

Development stage
Preclinical
Modality
Small Molecules
Administration
Intraocular, Intravitreal, Subretinal, Oral
01

Overview

Pyrogallol-o-sulfate is a small molecule metabolite derived from the consumption of (poly)phenol-rich foods, such as fruits, legumes, nuts, coffee, and red wine. It belongs to the class of phenylsulfates and is found circulating in human plasma. This compound is being investigated for its potential therapeutic benefits, particularly its neuroprotective, anti-inflammatory, and anti-angiogenic properties. Studies indicate its ability to reduce oxidative stress, decrease neuroinflammation, and attenuate cell death mechanisms relevant to neurodegenerative conditions like Parkinson's disease. Additionally, it has shown promise in diabetic retinopathy by decreasing microglial activation and inhibiting the expression of vascular endothelial growth factor (VEGF). Pyrogallol-o-sulfate is capable of crossing the blood-brain barrier, further supporting its potential in neurological applications.

Other names
Pyrogallol-1-O-sulphatePyrogallol1-O-sulphatePyrogallol 1-O-sulphatePyrogallol-2-O-sulfatePyrogallol2-O-sulfatePyrogallol 2-O-sulfatePyr-sPyrogallol sulfate(2,3-dihydroxyphenyl) hydrogen sulfate(2,6-dihydroxyphenyl) hydrogen sulfate
02

Targets

AIF1 (Allograft inflammatory factor 1)VEGFA (Vascular endothelial growth factor A)

Beyond the preview

Go deeper on pyrogallol-o-sulfate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pyrogallol-o-sulfate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call